Rising stocks yield 300,000 new US millionaires

Robert Frank , CNBC ? ? ? 3 hrs.

The rising stock market has pushed America's millionaire population close to its all-time highs before the recession.

According to data from Spectrem Group, the Chicago-based wealth research firm, there are now 8.99 million U.S. households whose net worth totals $1 million or more (not including primary residence). That's up from 8.6 million in 2011 and just short of the all-time record set in 2006, when the United States had 9.2 million millionaire households.

The stock market's rise has been the biggest driver of millionaire creation. With this year's gains, Spectrem said, the United States may have already exceeded its all-time record.

Most of the benefits from rising stocks have gone to the wealthy, since the top 10 percent of Americans own more than 80 percent of all stocks, according to research from Edward Wolff of New York University. But the recent stock surge has also created a new gap within the wealthy, or at least between millionaires and the so-called affluent.

According to Spectrem, the number of households worth $1 million or more, and $5 million or more is near the record. But the number of households worth $500,000 or more (the affluent) is much lower than the record in 2007. There are 14.3 million households worth $500,000 or more ? down from 15.7 million in 2007.

Catherine McBreen, president of Spectrem Group's Millionaire Corner, said that millionaire households held more stocks -- and therefore have benefited more from the market's run-up. It's not just a matter of money. Wealthier households also tended to make better investments, or at least more bullish ones, staying in the market during the recession while less wealthy investors bailed out.

Affluent households had more than half their investable assets in some kind of equities in 2005, but in 2012 it dropped to a third. Millionaire households have 71 percent of their investable assets in some form of equities -- up from 61 percent in 2005.

Read more: Surging Stocks Gives Ski Home Market a Lift

"The reason the affluents haven't recovered as quickly is their stock holdings," McBreen said. "Many of them simply pulled out of the market. They have more cash. But more of the high-net-worth households stayed in."

She said the millionaire households were more likely to be older and retired, so they could afford to keep more money in the market.

"The affluent group may be high earners, but they also might have high expenses like college tuition."

? 2013 CNBC LLC. All Rights Reserved

Source: http://www.nbcnews.com/business/rising-stocks-yield-300-000-new-us-millionaires-1C8865668

Elder Scrolls Online joe biden michelle obama lupe fiasco jason wu jason wu Mavericks Surf

Google's Pichai replaces Rubin at Android's helm

By Yereth Rosen ANCHORAGE, Alaska (Reuters) - The 2004 winner of Alaska's famed 1,000-mile sled-dog race, the Iditarod, won again at age 53 on Tuesday to become the oldest champion, a year after his son became the youngest winner. Mitch Seavey and his team of dogs sprinted across the finish line just 24 minutes ahead of Aliy Zirkle, who was bidding to become the first woman to win the Iditarod since 1990, when Susan Butcher claimed her fourth championship. ...

Source: http://news.yahoo.com/googles-pichai-replaces-rubin-androids-helm-171945897--sector.html

st louis blues rueben randle mike trout ryan broyles jerel worthy alshon jeffery miami heat

BitTorrent's P2P Streaming Takes the Lag Out of Live Video

Livestreams are great and all, but they're all subject to a terrible reality: the more people who want to watch, the more likely it is the stream goes down. BitTorrent's P2P streaming service BitTorrent Live stands to change all that by actually drawing strength from the crowd, and it's here to start shaking up the scene. More »

Source: http://feeds.gawker.com/~r/gizmodo/full/~3/fYBWj698geE/bittorrents-p2p-streaming-protocol-is-here-to-change-web-video-forever

Belk Led Zeppelin Ned Rocknroll Norman Schwarzkopf Avery Johnson netflix iTunes

Conclave cardinals by continent

Mar 11 (Reuters) - Leading money winners on the 2013 PGATour on Monday (U.S. unless stated): 1. Brandt Snedeker $2,859,920 2. Tiger Woods $2,671,600 3. Matt Kuchar $2,055,500 4. Steve Stricker $1,820,000 5. Phil Mickelson $1,650,260 6. Hunter Mahan $1,491,965 7. John Merrick $1,343,514 8. Dustin Johnson $1,330,507 9. Russell Henley $1,313,280 10. Michael Thompson $1,254,669 11. Charles Howell III $1,238,219 12. Brian Gay $1,171,721 13. Jason Day $1,080,664 14. Chris Kirk $1,004,053 15. Keegan Bradley $976,993 16. Josh Teater $883,229 17. Bill Haas $876,800 18. Scott Piercy $868,592 19. ...

Source: http://news.yahoo.com/conclave-cardinals-continent-094556760.html

east west shrine game underworld awakening haywire dog the bounty hunter tacoma narrows bridge open marriage department of justice

With Ammunition Costs On the Rise, Some Shooters Turn to ...

With Ammunition Costs On the Rise, Some Shooters Turn to Reloading

ShooterSurvey.com

FERNANDINA BEACH, Fla. --(Ammoland.com)- With soaring ammunition costs and shortages of cartridges on store shelves making headlines in recent months, many shooters are wondering how they are going to find or afford enough rounds to keep enjoying their sport as much as they always have.

For some, the answer?at least a partial one?has been found in reloading their own ammunition.

A recent ShooterSurvey.com and HunterSurvey.com poll found that approximately one-in-four respondents?just over 26 percent?said they reload.

Of those who participate in the activity, the top reason cited was to save money, followed closely by wanting to improve accuracy.

The chief motivations for reloading are:

• To save money 86%
• To improve accuracy 72%
• To obtain rounds difficult to find in stores 34%
• To reduce waste 28%
• Other 11%

Of those who chose other, the majority wrote in that they reload for fun, relaxation and enjoyment. Respondents could check more than one reason.

?Some people view reloading as a niche activity though these results show, with as many as a quarter of avid shooters assembling their own rounds, it is a popular activity,? says Rob Southwick, president of Southwick Associates, which designs and conducts the surveys at HunterSurvey.com, ShooterSurvey.com and AnglerSurvey.com.

Among the types of ammunition reloaded, rifle leads the way with 79 percent of reloaders putting together those rounds, followed by 60 percent who assemble handgun cartridges and 28 percent loading shotshells. Some people who reload do so with multiple types of ammunition.

To help continually improve, protect and advance angling and other outdoor recreation, all sportsmen and sportswomen are encouraged to participate in the surveys at HunterSurvey.com, ShooterSurvey.com and/or AnglerSurvey.com. Each month, participants who complete the survey are entered into a drawing for one of five $100 gift certificates to the sporting goods retailer of their choice.

About AnglerSurvey.com, HunterSurvey.com and ShooterSurvey.com:
Launched in 2006, AnglerSurvey.com, HunterSurvey.com and ShooterSurvey.com help the outdoor equipment industry, government fisheries and wildlife officials and conservation organizations track consumer activities and expenditure trends. Survey results are scientifically analyzed to reflect the attitudes and habits of anglers and hunters across the United States. Follow them on Facebook at http://facebook.com/huntersurvey and http://facebook.com/anglersurvey or on Twitter at https://twitter.com/#!/AnglerSurvey and https://twitter.com/#!/HunterSurvey.

Source: http://www.ammoland.com/2013/03/with-ammunition-costs-on-the-rise-some-shooters-turn-to-reloading/

michelle malkin october baby sugarland 16 and pregnant ludwig mies van der rohe jamie lynn sigler mega millions jackpot

New anti-clotting drug more effective than current treatment, study suggests

Mar. 10, 2013 ? Cangrelor, a novel intravenous anti-clotting medication, proves better across a broad population of patients receiving coronary stent procedures.

A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who underwent coronary stent procedures. These data, from the phase III CHAMPION PHOENIX study, were presented at the American College of Cardiology's 62^nd Annual Scientific Session and published simultaneously in the New England Journal of Medicine.

Researchers report that the new drug, which is administered intravenously, reduced the odds of complications from stenting procedures. Specifically, those who received cangrelor had a lower combined incidence of death, myocardial infarction, ischemia-driven revascularization, or stent thrombosis at 48 hours after randomization.

"We are very excited about the potential for this new medication to reduce complications in patients receiving coronary stents for a wide variety of indications. In addition to being much quicker to take effect and more potent than currently available treatment options, this intravenous drug is reversible and has a fast offset of action, which could be an advantage if emergency surgery is needed." said Deepak L. Bhatt, MD, MPH, lead author of the study, director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital (BWH) and chief of cardiology at VA Boston Healthcare System, as well as professor of medicine at Harvard Medical School.

In this randomized double-blind trial, researchers compared the novel IV drug cangrelor against the oral clopidogrel standard of care in approximately 11,000 patients at 153 centers around the world. The study included a wide selection of patients with different types of heart attack, angina, and other conditions for which people undergo percutaneous coronary intervention (PCI), as long as they did not have high risk for bleeding or recent exposure to other anti-clotting drugs.

Researchers report significantly better performance by cangrelor compared with clopidogrel:

• A 22 percent reduction in the odds of death, myocardial infarction, ischemia-driven revascularization, or stent thrombosis at 48 hours after randomization: 4.7 percent vs. 5.9 percent
• A 38 percent reduction in the odds of stent thrombosis at 48 hours: 0.8 percent vs. 1.4 percent
• Both treatment arms showed a quite low, statistically comparable incidence in severe bleeding at 48 hours: 0.16 percent vs. 0.11 percent.

Coronary artery stents are used in the majority of patients who undergo percutaneous coronary intervention (PCI), a common medical procedure used to treat arteries in the heart that have become narrowed or blocked due to coronary artery disease, which affects an estimated 14 million Americans. During this procedure, patients are regularly given oral doses of an anti-clotting agent to prevent blood clotting. Both cangrelor and clopidogrel interfere with the P2Y₁₂ receptor, a platelet-surface protein that helps regulate blood clotting.

"We are encouraged by these compelling results, especially as it relates to the safety data, and believe that this drug has the potential to offer dramatic benefits to our patients" said Robert A. Harrington, M.D., chairman of medicine at Stanford University School of Medicine and co-chair of the study.

The company plans to file for approval with the Food and Drug Administration using data from CHAMPION PHOENIX and the earlier BRIDGE trial.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

---

Story Source:

The above story is reprinted from materials provided by Brigham and Women's Hospital.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

---

Journal Reference:

1. Deepak L. Bhatt, Gregg W. Stone, Kenneth W. Mahaffey, C. Michael Gibson, P. Gabriel Steg, Christian W. Hamm, Matthew J. Price, Sergio Leonardi, Dianne Gallup, Ezio Bramucci, Peter W. Radke, Petr Widimsk?, Frantisek Tousek, Jeffrey Tauth, Douglas Spriggs, Brent T. McLaurin, Dominick J. Angiolillo, Philippe G?n?reux, Tiepu Liu, Jayne Prats, Meredith Todd, Simona Skerjanec, Harvey D. White, Robert A. Harrington. Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events. New England Journal of Medicine, 2013; : 130310091208003 DOI: 10.1056/NEJMoa1300815

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/qutnxvX2dZk/130311101823.htm

brad paisley zac brown band aubrey born to run pranks pregnancy test april fools day 2012

A Spring Break to Remember

The National Weather Service on Monday said that this week?s conditions could be named ?Goldilocks Weather? because it?s just right.? Enjoy a comfortable night ahead.? Be sure to check out the Comet Pan-STARRS over the next few evenings.? Just look in the western sky about 30 minutes after sunset (around 8 to 8:15pm our time) to see the light streaks.? Tonight?s?action will be near the crescent?moon.? Enjoy the comet show each evening thru the beginning of next week.

?

The rest of the week will feature warming temperatures into the 80s!? Spring fever! There is a slight chance of showers by the start of next week.

?

The bad news of having a dry Spring Break is that we miss out on another opportunity for beneficial rainfall to help North Texas climb out of drought.? 76% of the state is in drought.

?

Unfortunately without a strong signal that El Nino is forming, the overall weather pattern is forecast to remain drier than normal.? This means that Texas will remain in drought and it could get worse as we approach summer.

Source: http://dfw.cbslocal.com/2013/03/12/a-spring-break-to-remember/

the three stooges the bee gees woodward keratosis pilaris rock and roll hall of fame 2012 brandon rios oklahoma news